President & CEO
Tom has 35 years of experience in the field of pharmaceutical, biologic, device and aesthetic-related sales, marketing and general management roles. He joined the Company in April 2017 as CEO. Since 2011, he had been Chairman and CEO of Andrew Technologies LLC, an aesthetic surgical device company. From 2010 to 2011, he was president of the topical aesthetic division at Syneron Medical Ltd, a global medical aesthetic device company. From 2008 to 2010, he was head of North American marketing at Nobel Biocare, a leading dental aesthetics company. His medical aesthetic experience commenced with Allergan (2000 – 2008), where he led the launch of BOTOX® Cosmetic and the commercial development of Latisse®. He was also the alliance manager for the collaboration between Allergan and GlaxoSmithKline in China, Japan and the US. In 1983, he commenced his career in healthcare with the Parke-Davis division of Warner Lambert, where he held sales and marketing leadership roles, including the 1997 launch of Lipitor®, among other brands. Tom is also currently on the Board of Recros Medica, Bonti Inc and Andrew Technologies. Prior to beginning his healthcare career, Tom was an officer in the US Air Force. Tom has a BS in biology from The Citadel and an MBA in marketing from Mercer University.